Introduction
Neurocognitive disorders (NCDs), defined in accordance with the Diagnostic and Statistical Manual, Edition 5: DSM-5 criteria, are an umbrella term for cognitive disorders formerly known as dementia [1, 2] . Some examples include major NCDs due to Alzheimer's disease (AD), vascular disease, or Parkinson's disease. Mild neurocognitive impairment, also termed mild cognitive impairment, can be a prodromal state of major NCD. Both incidence and prevalence increase with age [3] , with substantial costs representing a challenge for the economy [4] . For individuals with NCDs, changes in cognition, behavior, and emotions can lead to progressive and irreversible functional limitations, affecting everyday activities and autonomy [5] .
Virtual reality (VR) is an emerging technology that digitally provides a three-dimensional environment, allowing persons to interact, provide sensory inputs, and track changes [6] . VR can be presented in fully immersive (high level of immersion) or nonimmersive environments (low level of immersion) [7, 8] . Immersion provides a sense of presence in the virtual world with an immersive display device (e.g. head-mounted display) and an interactive device (e.g. joystick, glove). VR has been used in health care and education for both rehabilitation and training purposes [9] [10] [11] [12] . VR technologies are an innovative rehabilitation approach to minimize the negative impact of NCDs on individuals, families, and society.
VR has been successfully used in the elderly and in individuals who had stroke and Parkinson's disease to enhance the ability to perform activities of daily living [13] , in individuals at high risk for cognitive decline [14] to reduce anxiety in older adults consulting for the first time in a memory clinic [15] , and in individuals with NCDs for memory rehabilitation [16] . Interestingly, VR has been used in the diagnosis, cognitive training, and caregiver education for major NCD due to AD [17, 18] , to improve executive function in individuals with NCDs due to traumatic brain injury [19] , cognitive rehabilitation of mild cognitive impairment [20] [21] [22] , and stroke [23, 24] . The evidence is sparse, and a comprehensive picture of the effects of VR interventions on NCDs is needed. That is, an overall description of the use of VR in the cognitive rehabilitation of NCDs remains predominantly undetermined. We aim to systematically review VR studies focused on cognitive rehabilitation in NCDs. As a secondary objective, we aimed to identify changes in psychological functioning (e.g. improved wellbeing and reduction of emotional problems) after VR interventions in NCDs.
Methods

Search strategy and information sources
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) systematic review was conducted using the keywords ("Dementia" OR "Cognitive impairment") and ("Virtual reality" OR "Virtualbased") with different combinations of those terms in the databases MEDLINE/PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, LI-LACS, SciELO, PEDro, CINAHL, and Scopus from inception to November 2018. A librarian and a clinical neuropsychologist helped the team to refine the search strategy and the search was cross-validated by a second librarian. A reference manager software was used -EndNote X9 [25] .
The systematic review has been registered in PROS-PERO: (registration number: CRD42019121953).
Study selection
Eligibility of the studies followed inclusion criteria: (1) VR interventions conducted in adults with NCDs of different etiologies (e.g. AD, vascular disease, Parkinson's disease, and mild cognitive impairment); (2) Studies conducted in the community, hospital, or residential care; (3) Studies measuring cognition before and after VR interventions. Interventions included the use of any type of immersive and nonimmersive VR technology targeting cognition in individuals with NCDs; (4) Quantitative, qualitative, and mixed studies; (5) Feasibility studies (i.e., user acceptance and adverse effects); and (6) Studies available in the English language. We excluded studies based on the following characteristics: (1) Studies conducted in individuals with traumatic brain injury and delirium; (2) Studies focusing on family or professional caregivers of individuals with NCD or outcome measures that focused on family members and professional caregivers of individuals living with NCD;
(3) Research protocols and reviews; (4) Expert letters, opinion pieces, notes, editorials, and book chapters; and (5) Conference papers and abstracts.
Data extraction and synthesis
First, titles and abstracts were screened by two independent reviewers (i.e., a researcher in VR and a clinical neuropsychologist) based on the eligibility criteria. Studies meeting the inclusion criteria, or studies that were unclear, were retained for full-text review. Discrepancies were resolved by consensus and a third reviewer for determination. Second, two reviewers independently extracted the following information from each study: Publication data (i.e., author, year, and title), study design, objectives, setting, participants (e.g. sample size, mean age, sex, ethnicity, diagnosis, NCD severity, NCD duration, and the demographic information for control groups when available), VR intervention (i.e., name of the VR application, technical information, subjective and objective level of immersion based on published guidelines [7] , the number of VR sessions and frequency, length of each VR session, and VR overall mean duration), outcome measures, results, user acceptance, adverse effects, generalization, and the general conclusion.
Levels of VR immersion
The level of immersive capability of VR technologies was assessed using five criteria [7, 8] : (1) Inclusiveness that refers to whether a VR technology eliminates signals indicating the existence of a physical world separate from the virtual world (e.g. joystick, weight of wearable devices, and external noise); (2) Extensiveness refers to the number of sensory modalities accommodated; (3) Surrounding involves the visual presentation of the VR technology, to which the physical world is shut out (e.g. head-mounted display, surround projection, and computer screen); (4) Vividness corresponds to the fidelity and resolution with which the VR technology simulates the desired environment (e.g. visual information and functionality); and (5) Matching to whether the viewpoint of the VR technology is modified to match the user's perspective through motion capture.
Each one of the five criteria influences, but may not be the sole determinant of, the user's perceptual experience [7, 8] . In this systematic review, we objectively classified VR technologies as low, moderate, or highly immersive based on the extent to which they met [7] criteria. When a study differed in the level of immersion across multiple aspects, we averaged across criteria to determine a global immersion rating. For example, if a VR technology met low criteria on one aspect, moderate criteria on three aspects, and high criteria on one aspect, it was classified as moderate immersion. The numerical score was calculated by converting the scores of each aspect into a numerical value (low 5 1, moderate 5 2, and high 5 3) to estimate an overall mean score for each VR technology.
Risk of bias and quality assessment
Two reviewers independently appraised the included studies using the Downs and Black tool (1998). The tool contains 27 questions across five sections and provides both an overall score for study quality and a bias score. The five sections included (1) study quality -10 items, (2) external validity -3 items, (3) study bias -7 items, (4) confounding and selection bias -6 items, and (4) power of the study -1 item. Items are scored from 0 ("no") to 1 ("yes"), excepting item 5 (scores ranging from 0-2; 0 5 no; 1 5 partially, and 2 5 yes) and item 27 (scores ranging from 0-5; 0 5 No power calculation is provided; 3 5 The power calculation is provided but the importance or impact of the difference between groups used in the calculation is unclear; 5 5 The difference between groups is clearly defined as a clinically important difference.) Downs and Black total score ranges were given in corresponding quality levels: (1) excellent (26), (2) good (20-25), (3) fair (15) (16) (17) (18) (19) , and (4) poor (14) [26] . Only randomized studies could achieve a quality level of excellent in accordance with the scoring methodology of the Downs and Black checklist.
Strategy for data synthesis
A critical analysis of the literature was performed based on (1) a descriptive numerical summary based on the characteristics of the studies, samples, diagnoses, and types of VR technologies; (2) level of immersion; and (3) risk of bias and quality assessment of the studies. Based on the information available, the suitability of a meta-analysis was considered.
Results
Of 404 studies, a total of 22 were included in the systematic review, for an aggregated sample of 564 individuals with NCDs participating in these studies ( Fig. 1) . Given the variability in study outcomes, it was not feasible to conduct a meta-analysis. Most of the included studies were conducted in individuals with NCDs due to stroke (27.3%) [27] [28] [29] [30] [31] [32] , followed by mild cognitive impairment (22.7%) [33] [34] [35] [36] [37] , and AD (13.6%) [38] [39] [40] . In addition, 13.6% of the 22 studies included samples with nonspecified NCD [38] [39] [40] , and 22.7% included groups with suspected NCD (e.g. questionable dementia and presence of memory deficits), multiple sclerosis, or diagnosis not confirmed [41] [42] [43] [44] [45] .
Clinical information
Information of each study including the objective, clinical characteristics of the sample, main outcomes, and results is presented in Table 1 . The Mini-Mental State Examination [49] was the most widely used tool to determine the severity of the NCDs with a wide range in the scores (10-30), followed by the Montreal Cognitive Assessment [50] with scores ranging from 18 to 30 points. Outcome measures include traditional neuropsychological tests (e.g. Rey Auditory Verbal Learning Test and Trail Making Test), as well as measures of suitability and acceptability. In general, the results of the interventions indicate an improvement at different levels of cognition (e.g. memory, dual tasking, and visual attention). Secondarily, a reduction in psychological aspects was confirmed after VR interventions targeting cognition (e.g. reduction of anxiety, higher levels of well-being, and increased use of coping strategies). Only one study showed no change in cognitive outcomes after the VR intervention most likely related to the relatively short training period and lack of training specificity for improving cognitive performance [37] . The rest showed positive outcomes or the feasibility to deliver the intervention. However, most of the studies did not report effect sizes (see Table 1 ). Table 2 shows different VR levels of immersion as reported in the studies, the characteristics of the VR programs, and user experience. In regard to the description of the levels of immersion, as provided in the studies, 50% of the technologies were described as semiimmersive, 18.2% as immersive, 18.2% as nonimmersive, and 13.6% did not describe the level of immersion. The average number of sessions delivered for the 22 studies was 13.8 (SD 5 14, range 5 1-60). The average duration of a single session across the 22 studies was 31.4 minutes (SD 5 11.3, range 5 5-50). A total of 40.9% of the studies did not report any data regarding user acceptance. On average, the remaining studies indicated a good level of acceptance associated with enjoyment with the technology, user satisfaction, interest, engagement, motivation, safety, helpfulness, and easiness of use. Interestingly, adverse effects were not reported in 59.1% of the studies. Among the adverse effects reported, the most frequent ones included simulator sickness [38] , negative emotions when participants fail in specific activities facilitated by the technology [33] , oculomotor disturbances, nausea, and disorientation [47] , neck pain [31] , and some dizziness [44] . Only one study clearly indicated an absence of trainingrelated adverse events [37] . The remaining studies indicated no adverse effects. Table 3 shows the objective levels of immersion based on the aforementioned criteria [7, 8] . Most of the studies (40.9%) met the criteria for a moderate level of immersion, followed by 27.3% of high level of immersion, and 13.6 of low immersive experience. Surprisingly, the information about the immersive criteria allowing rating of the degree of immersion of the VR technology was not available in 18.2% of the studies.
VR technology and reported levels of immersion
Objective level of immersion
Risk of bias and quality assessment
A total quality score was calculated by rating the individual items in each of the five domains. The tool does not provide a cutoff score to classify the studies into either a low-or high-quality study, avoiding the artificial classification. The average quality score for the studies was 17.7 (SD 5 4.1, range 5 10-27), out of 31 possible points. We included case studies as part of this review. Table 4 presents the percentage of the studies that met the criteria in the checklist. The analysis of Reporting, which assessed whether the information provided in the article was sufficient to allow a reader to make an unbiased assessment of the findings of the study, revealed that the distributions of principal confounders in each group of participants to be compared were not clearly described and that all important adverse events that may be a consequence of the intervention have not been reported. On average, reporting scores were high (7.8 of 10, SD 5 1.6, range 5 5-10).
External validity, addressing the extent to which the findings from the studies could be generalized to the population from which the study participants were derived, indicates that the staff, places, and facilities where the participants were treated were not representative of the treatment the majority of clients receive. In almost 40%, the interventions were delivered in a university laboratory, which makes sense given that these are new treatments and that some of them correspond to feasibility studies. On average, external validity scores were high (1.3 of 3, SD 5 1.1, range 5 0-3).
The analysis of Bias, which addressed biases in the measurement of the intervention and the outcome, revealed that there was not an attempt made to blind study participants to the intervention they have received. On average, Bias scores were high (4.4 of 7, SD 5 1, range 5 2-6).
Confounding, that addressed bias in the selection of study participants revealed that there was not adequate adjustment for confounding in the analyses from which the main findings were drawn. However, average confounding scores were moderate (2.9 of 6, SD 5 1.4, range 5 0-5).
Finally, the item evaluating Power, or whether the negative findings from a study could be due to chance indicated that only 31.8% of the studies had sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%. In addition, average Power scores were low (1.2 of 5, SD 5 1.9, range 5 0-5).
Based on the criteria to classify Downs and Black score ranges [26] , none of the studies reached excellent quality levels (26) . A total of 10 studies reached good quality levels (20) (21) (22) (23) (24) (25) [27, 29, 30, [32] [33] [34] 38, 39, 41, 47] , seven reached fair quality levels (15) (16) (17) (18) (19) [31, 36, 37, [42] [43] [44] 48] , and only five reached poor quality levels (14) [28, 35, 40, 45, 46] .
Discussion
The present systematic review was conducted to study the effects of virtual reality on overall cognitive and psychological rehabilitation in individuals with NCDs. We provided descriptive analyses based on the characteristics of the studies, study samples, diagnoses, types of VR technologies, subjective and objective levels of immersion, and the risk of bias and quality assessment of 22 studies with an aggregated sample of 564 individuals with NCD. We extracted the information with two independent reviewers to increase the accuracy in the process. The main finding is that the results of the VR interventions in individuals with NCDs indicate an improvement at different levels of cognition (e.g. memory, dual tasking, and visual attention) and an improvement in psychological functioning (e.g. reduction of anxiety, higher levels of well-being, and increased use of coping strategies). VR interventions have been mainly used in individuals with NCDs due to stroke, followed by individuals with mild cognitive impairment and AD. The evidence provided in this systematic review supports the use of VR interventions as a way to provide cognitive rehabilitation and to treat psychological symptoms in individuals with NCDs of different etiologies.
Most of the VR technologies reported subjective levels of immersion described as semi-immersive. The average number of sessions was close to 14, with a duration of approximately 30 minutes each, two or three times per week. As such, VR interventions were primarily delivered in university laboratories or hospital facilities as part of innovation initiatives. Although almost 40% of the studies did not report acceptability, VR interventions seem to be greatly accepted by individuals with NCDs (e.g. enjoyment with the technology, user satisfaction, interest, engagement, motivation, safety, helpfulness, and easiness of use). Adverse effects do not seem to be exclusive of NCDs (e.g. simulator sickness, negative emotions when participants fail in specific activities facilitated by the technology, oculomotor disturbances, nausea, disorientation, neck pain, and some dizziness), as they have been reported in only 5% of participants in a study of VR aiming to document those effects [51] . As such, adverse effects need to be monitored but do not represent a reason for exclusion on their own. Most of the studies met objective criteria for moderate levels of immersion. Higher levels of immersion can increase the user experience and play a major role in the sense of presence. The sense of presence corresponds to the experience of actually feeling "being there," as in a real-world situation, which is vital to substantially affect the behavioral responses [17] . In the present state of the literature, we do not know if a fully immersive VR technology is better than a moderate or low immersive VR technology in individuals with NCDs.
Although the overall quality of the studies was good, it is important to insist on the documentation of adverse effects, make sure to attempt to blind study participants to the intervention they receive, and make sure to adjust for confounding in the analyses from which the main findings are drawn and increase power. In regard to the external validity, the results of this systematic review indicate that the staff, places, and facilities where the participants were treated were not representative of the treatment the majority of clients receive. This was expected as VR technologies are being developed, and their use is in the early stages. There were no studies that could achieve a quality level of excellent in accordance with the scoring methodology of the Downs and Black checklist. As such, future research needs to focus on randomized controlled studies.
Conclusion and recommendations for research and practice
In conclusion, we presented a systematic review of the literature on VR technologies for the rehabilitation of cognition and psychological functioning in minor and major NCDs. VR interventions are useful to improve cognition (e.g. memory, dual tasking, and visual attention) and psychological functioning (e.g. reduction of anxiety, higher levels of well-being, and increased use of coping strategies) in individuals with NCD. VR interventions are mainly used in individuals with NCDs due to stroke. Although this systematic review was not suitable for a meta-analysis, the results indicate that VR interventions are helpful and promising in providing cognitive rehabilitation and to treat psychological symptoms in individuals with NCDs of different etiologies, which should be further explored in future with welldesigned studies.
Based on the conclusions of the present review, the following recommendations for future studies can help to increase research in individuals with NCDs.
1. To describe the clinical information of the samples.
The type and severity of NCD are very important to be able to compare findings across studies. The use of widely known instruments to track cognitive changes (e.g. MMSE and MoCA) and a clear diagnosis allow clinicians to easily identify candidates for these interventions.
To conduct longitudinal studies on VR interventions
of NCDs. Longitudinal studies allow capturing the progression of NCDs and help to observe whether the benefits of the VR interventions are maintained with the evolution of the disease. 3. To compare different levels of immersion. To date, we do not know whether higher levels of immersion are more effective to treat cognitive and psychological problems in individuals with NCDs, as compared to lower levels of immersion. 4. To systematically assess user acceptance and adverse effects. We do not know whether adverse effects or acceptance levels differ in NCDs of different etiologies or in the same NCD at different stages of the disease. 5. To use widely known measures for cognition and psychological outcomes showing cross-cultural validity. The use of core instruments that have been developed and used in different cultures will allow performing a meta-analysis and facilitate comparisons across studies. 6. Report effect sizes for all the outcomes. This will allow readers to have a better appreciation of the effect of VR interventions on cognition. 7. Provide examples of generalization to real-life situations. This could provide evidence that the results of VR interventions have an impact on the everyday life of individuals with NCDs. Measures can be collected through family caregiver reports or professional caregivers.
RESEARCH IN CONTEXT
1. Systematic review: The authors conducted a systematic review of the published literature on immersive and nonimmersive virtual reality technologies targeting cognition in minor and major neurocognitive disorders following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
2. Interpretation: Virtual reality interventions are useful to improve cognition (e.g. memory, dual tasking, and visual attention) and psychological functioning (e.g. reduction of anxiety, higher levels of well-being, increased use of coping strategies) in individuals with minor and major neurocognitive disorders.
3. Future directions: To improve research in this area, we recommend to describe the clinical information of the samples, to conduct longitudinal studies on virtual reality interventions of neurocognitive disorders, to compare different levels of immersion, to systematically assess user acceptance and adverse effects, to use widely known measures for cognition and psychological outcomes showing cross-cultural validity, to report effect sizes for all the outcomes, and to provide examples of generalization to real-life situations.
